I D Biopharma, was formed via the consolidation of infectious disease technologies from Virogenomics and additional technologies from Oregon Health & Science University (OHSU). Few biotechnology and pharmaceutical companies focus on the development of vaccines, therapeutics and diagnostics for infectious diseases and the majority of research funding in this area is, therefore, left to federal agencies. By leveraging its relationships with the major research universities in an entrepreneurial environment, IDB is unique in the infectious disease arena. The IDB team has proven experience in raising equity capital, planning and implementing drug development strategies, obtaining patent protection and regulatory approval, and managing product manufacturing and all other aspects involved in the commercialization of biotechnology products.
ID Biopharma is a wholly owned subsidiary of Virogenomics Inc.